General Information of the Compound
Compound ID |
CP0004988
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate
Show/Hide
|
||||||||||||||||||
Synonyms |
3-Pyridinylmethyl ((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)carbamate
Carbamic acid, ((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)-, 3-pyridinylmethyl ester
Carbamic acid, [[4-[[(2-aminophenyl)amino]carbonyl]phenyl] methyl]-, 3-pyridinylmethyl ester
Carbamic acid, [[4-[[(2-aminophenyl)carbaonyl]phenyl]methyl]-, 3-pyridinylmethyl ester
Entinostat
Entinostat (USAN/INN)
Entinostat, SNDX-275, MS-27-275, MS-275
Histone Deacetylase Inhibitor I
IN1470
MS 27-275
MS 275
MS-27-275
Ms-275
N-(2-Aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)aminomethyl]benzamide
N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide
Pyridin-3-ylmethyl 4-(2-aminophenylcarbamoyl)benzylcarbamate
Pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate
Pyridin-3-ylmethyl {4-[(2-aminophenyl)carbamoyl]benzyl}carbamate
Pyridin-3-ylmethyl{4-[(2-aminophenyl)carbamoyl]benzyl}carbamate
SNDX 275
SNDX-275
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C21H20N4O3
|
||||||||||||||||||
Molecular Weight |
376.416
|
||||||||||||||||||
Canonical SMILES |
Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C21H20N4O3/c22-18-5-1-2-6-19(18)25-20(26)17-9-7-15(8-10-17)13-24-21(27)28-14-16-4-3-11-23-12-16/h1-12H,13-14,22H2,(H,24,27)(H,25,26)
Show/Hide
|
||||||||||||||||||
InChIKey |
INVTYAOGFAGBOE-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
209783-80-2
442532-99-2
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00894, Androgen receptor
Protein ID: PT00285, Histone deacetylase
Protein ID: PT00991, Histone deacetylase 1
Cell-based Assay
Biochemical Assays
Protein ID: PT00835, Histone deacetylase 2
Cell-based Assay
Biochemical Assays
Protein ID: PT00995, Histone deacetylase 3
Cell-based Assay
Cell Line ID | Cell Line Name | Cell Line Organism | |
CL000006 | HEK293 | Homo sapiens (Human) | 1 |
1 |
IC50 = 400 nM
|
TI
LI
LO
TS
|
---|
Biochemical Assays
Protein ID: PT00994, Histone deacetylase 4
Protein ID: PT00996, Histone deacetylase 5
Protein ID: PT01213, Histone deacetylase 6
Protein ID: PT01807, Histone deacetylase 7
Protein ID: PT01499, Histone deacetylase 8
Protein ID: PT01946, Histone deacetylase 9
Protein ID: PT01443, Polyamine deacetylase HDAC10
Clinical Information about the Compound